The Faculty of Population Health Sciences possesses significant capacity and capability to support enterprise. Whilst it has a long tradition of knowledge transfer and impact, as well as engagement with external partners such as GSK, BioMarin and Genzyme, the historic focus of FPHS’s work has been to contribute direct input to policy making, clinical guideline development and health service configuration.

Areas of expertise offered through enterprising activities such as consultancy include gene and stem cell treatment, diagnostic markers, neonatology and prenatal therapies, along with high quality analytic and statistical expertise in relation to observational and trial data.

A snapshot of the range of expertise can be found in the SLMS Enterprise publication, and advice on working with the Faculty and School is provided through two main offices:

The School of Life and Medical Sciences Translational Research Office, which provides wide-ranging support for the development of industry partnerships and translational research. The TRO Industrial Partnerships Group focuses on identifying opportunities for new partnerships, matching industry needs with academic research interests and capability, and managing established partnerships to ensure mutually beneficial and successful outcomes.

In addition, UCL Consultants provides a one-stop service for the provision of academic consultancy, expert witness, testing & analysis and bespoke training and short course services to external clients on behalf of UCL academics and departments. They make it as easy and productive as possible for our academics and external clients to work together by being the single port of call that connects them both.  

Consultancy helps solve problems for our clients and for society, and in so doing it generates impact, income, relationships and profile for our academic community.  An example of this is the recent collaboration between UCL and the Centre for Health and Infection Diseases Research in Copenhagen.  This follows the long-term clinical prognosis for the general population of 18,000 HIV-infected patients living in Europe and assesses the impact of antiretroviral drugs on the long-term prognosis for these patients.

Andy Duncan is the Consultancy Manager covering FPHS and represents a first point of contact for academics wishing to undertake consultancy work and clients wishing to work with FPHS.